This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
How Do I Listen?
|Find us in iTunes under the name HelixTalk
||Add us to your mobile app via our RSS feed
||Listen to any past episode in your browser (below)
Would you like to recommend content for a new podcast episode or provide your own commentary about a previous episode? We love feedback from our listeners! To contact us, please email Sean Kane (firstname.lastname@example.org).
Episode 24 - Case vignettes of depression, hypertension, and diabetes mellitus
April 7, 2015
In this episode, we discuss the optimal drug therapy for three different case vignettes -- depression, hypertension, and diabetes mellitus.
Episode 23 - Hepatitis C
March 16, 2015
In this episode, we review historical and new treatment options for hepatitis C, including: peginterferon, rivabirin, boceprevir, telaprevir, sofosbuvir (Sovaldi), simeprevir (Olysio), ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak), and ledipasvir/sofosbuvir (Harvoni).
Episode 22 - Sedation Minimization
March 3, 2015
In this episode, we discuss the pharmacology of oversedation, the importance of sedation minimization strategies in mechanically ventilated patients, and overview the sedatives and analgesics commonly used in this patient population.
Episode 21 - Opioid-Induced Respiratory Depression, Reversal, and Non-Narcotic Alternatives
February 10, 2015
In this episode, we discuss risk factors for opioid-related adverse events, naloxone (Narcan, Evzio), and a number of non-narcotic agents for neuropathic pain.
Episode 20 - SMART
January 20, 2015
In this episode, we summarize and discuss the clinical implications of the SMART trial (Salmeterol Multicenter Asthma Research Trial; Nelson et al, 2006).
Episode 19 - Immunizations
December 16, 2014
In this episode, we discuss two controversial topics in the world of immunizations with Dr. Angelo -- the "high-dose" influenza vaccine and the expanded use of PCV13 (Prevnar-13).
Episode 18 - HIV
December 2, 2014
In this episode, we review HIV therapy with Dr. Cottreau with a particular focus on Truvada, Atripla, Complera, Stribild, and Triumeq.
Episode 17 - Overactive bladder
November 18, 2014
In this episode, we discuss the management of overactive bladder, including: oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), trospium (Sanctura), solifenacin (VESIcare), darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), and onabotulinumtoxinA (Botox).
Episode 16 - New diabetes medications
November 4, 2014
In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).
Episode 15 - Cancer Screenings
September 23, 2014
In this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels.
Episode 14 - Midyear Table Talk
September 23, 2014
In this episode, we have a roundtable discussion regarding ASHP Midyear and the process of pursuing a pharmacy residency program.
Episode 13 - Obesity Guidelines and Weight Loss Pharmacotherapy
September 23, 2014
In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
Episode 12 - Osteoporosis Guidelines and Two Newer Agents
September 9, 2014
In this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo).
Episode 11 - Bordetella pertussis
August 26, 2014
In this episode, we discuss Bordetella pertussis (whooping cough) with Dr. Michael Fennewald.
Episode 10 - Pet Peeves
August 12, 2014
In this episode, we discuss our clinical "pet peeves" covering allergy histories, creatinine clearance, surrogate endpoints, "me too" enantiomer drugs, and dose-dependent pharmacology of psychiatric medications.
Episode 9 - Combining ACE-I, ARB, and DRIs
July 29, 2014
In this episode, we discuss the pharmacology of the renin-angiotensin-aldosterone system and review the evidence for combining ACE-Is, ARBs, and/or DRIs.
Episode 8 - HCAP, HAP, and VAP
July 15, 2014
In this episode, we discuss the 2005 ATS/IDSA Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia Guidelines (HCAP, HAP, VAP).
Episode 7 - Community-Acquired Pneumonia Guidelines
July 1, 2014
In this episode, we discuss the 2007 ATS/IDSA Community-Acquired Pneumonia (CAP) guidelines.
Episode 6 - Updates to GOLD Guidelines and COPD
June 17, 2014
In this episode, we discuss updates to the GOLD guidelines for COPD and review the newer agents for COPD including roflumilast (Daliresp), indacaterol (Arcapta Neohaler), aclidinium (Tudorza Pressair), umeclidinium/vilanterol (Anoro Ellipta), and fluticasone/vilanterol (Breo Ellipta).
Episode 5 - Smoking Cessation
June 3, 2014
In this episode, we discuss smoking cessation, including nicotine replacement therapy, bupropion (Zyban), and varenicline (Chantix).
Episode 4 - P2Y12 Inhibitors, DAPT, and TOAT
May 20, 2014
In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT).
Episode 3 - Novel Oral Anticoagulants (NOACs)
May 6, 2014
In this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis).
Episode 2 - Antihypertension Guidelines (JNC 8 and more)
April 22, 2014
In this episode, we discuss the new JNC 8 guidelines and how these guidelines differ from other hypertension guidelines released in 2013-2014.
Episode 1 - 2013 ACC/AHA Lipid Guidelines
April 8, 2014
In this episode, we discuss the new, rebranded podcast (HelixTalk) and review the new ACC/AHA 2013 lipid guidelines.
Past Episodes - Top 200 Drugs Podcast (pre-HelixTalk)
Women’s Health – Spring 2013, Week 10
April 25, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss women’s health: conjugated estrogens, ethinyl estradiol, norethindrone, norgestrel, etonogestrel, medroxyprogesterone, raloxifene, tamoxifen, miconazole, Midol, phenazopyridine.
GI Medications – Spring 2013, Week 9
April 17, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss GI medications: methotrexate, allopurinol, mesalamine, esomeprazole, pantoprazole, rabeprazole, sucralfate, dicyclomine, simethicone, pyrantel, and lactase enzyme.
Antiemetics, Antitussives, Antihistamines – Spring 2013, Week 8
April 9, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antiemetics, antitussives, and antihistamines: hydroxyzine, meclizine, metoclopramide, prochlorperazine, ondansetron, chlorpheniramine/hydrocodone, promethazine/codeine, desloratadine, dimehydrinate, benzoyl peroxide, and salicylic acid.
Men’s Health – Spring 2013, Week 7
April 3, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss men’s health: terazosin, doxazosin, tamsulosin, finasteride, sildenafil, vardenafil, tadalafil, oxybutynin, tolterodine, minoxidil, and nonoxynol-9.
Muscle Relaxants, Stimulants, Anticonvulsants – Spring 2013, Week 5
March 20, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss muscle relaxants, stimulants, and anticonvulsants: baclofen, carisoprodol, metaxalone, cyclobenzaprine, methylphenidate, Adderall, lisdexamfetamine, phenytoin, divalproex, DEET, tolnaftate, and eucerin.
Antidepressants, Antipsychotics – Spring 2013, Week 4
March 14, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants and antipsychotics: bupropion, venlafaxine, aripiprazole, quetiapine, risperidone, olanzapine, carbidopa/levodopa, pramoxine, Neosporin, and povidone/iodine.
Antidepressants – Spring 2013, Week 3
March 5, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants: citalopram, escitalopram, sertraline, fluoxetine, paroxetine, duloxetine, amitriptyline, trazodone, fexofenadine, oxymetazoline, and pheniramine.
Sleep Agents, Neuropathic Pain – Spring 2013, Week 2
February 26, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss sleep agents and neuropathic pain: alprazolam, clonazepam, diazepam, lorazepam, zolpidem, zaleplon, gabapentin, pregabalin, and lidocaine.
Osteoporosis – Winter 2012, Week 11
January 31, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for osteoporosis: calcitonin, alendronate, risedronate, ibandronate, potassium chloride, and calcium citrate.
COPD, Asthma – Winter 2012, Week 10
January 26, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for COPD and asthma: albuterol, levalbuterol, ipratropium, tiotropium, albuterol/ipratropium, fluticasone, mometasone, fluticasone/salmeterol, and formoterol/budesonide.
Opioid Analgesics – Winter 2012, Week 9
January 16, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss opioid analgesics: morphine sulfate, codeine/APAP, oxycodone, oxycodone/APAP, hydrocodone/APAP, hydrocodone/ibuprofen, fentanyl, and bisacodyl.
Pain Relievers – Winter 2012, Week 8
January 14, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss pain relievers: meloxicam, celecobix, ketorolac, tramadol, tramadol/APAP, capsaicin, and methyl salicylate.
Antifungals, Antivirals – Winter 2012, Week 7
January 14, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antifungals and antivirals: fluconazole, itraconazole, ketoconazole, oseltamivir, acyclovir, valacyclovir, docosanol, terbinafine, and clotrimazole or miconazole.
Antibiotics – Winter 2012, Week 6
January 14, 2013
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antibiotics: metronidazole, clindamycin, doxycycline, nitrofurantoin, sulfamethoxazole/trimethoprim, mupirocin, zinc oxide, and polyethylene glycol 400.